Sudden Hearing Loss Clinical Trial – Overview
A new clinical research study (study # STU00212929; clinicalTrials.gov ID, NCT04826237) in Otolaryngology (the department that focuses on ears, nose and throat) at Northwestern Medicine wants to improve the standard of care for sudden hearing loss by comparing the usual steroid treatment (standard of care) to one that also includes a short-term dose (7-day) of oral statin. Statin is a medication that is already widely used in human medicine to treat high blood cholesterol.
Click on the links above for more information and to contact the study team.